As of Feb 21, 2025, Incyte Corporation Intrinsic Value is $72.5. This suggests it may be undervalued by 0.5% compared to its current price of around $72.1.

What is Incyte Corporation DCF (discounted cash flow) valuation?

As of Feb 21, 2025, Incyte Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $69.3. This suggests it may be overvalued by 3.9% to its current price of around $72.1, using a discount rate of 7.7% and terminal growth rate of 3.0%.

Is Incyte Corporation overvalued or undervalued?

Incyte Corporation is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $72.5, compared to a market price of around $72.1. This suggests a potential undervaluation of 0.5%.